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Abstract
Objectives: Coronary artery bypass grafting (CABG) and combined stent-grafting (SG) were evaluated to reduce morbidity and mortality of
patients with descending or infrarenal aortic aneurysm. Methods: CABG and SG (thoracic n ¼ 6, infrarenal n ¼ 36) were performed during the
same hospitalization in 42 patients (mean age of 73 ^ 14 years). In 29 patients (mean Euroscore: 9), SG was performed under local anesthesia
9 ^ 3 days after coronary surgery (simultaneous) and in 13 patients (mean Euroscore: 7) during the same anesthesia (synchronous). In the latter
group, 11 out of 13 patients underwent off-pump CABG. All aneurysms were treated by implantation of commercially available self-expanding
grafts. Results: CABG was successful in all, but one patient with left internal mammary artery hypoperfusion syndrome, requiring an additional
distal saphenous graft to the left anterior descending coronary artery. SG was uneventful in 98% (41/42 patients). Postoperative computerized
tomography showed incomplete sealing in sevenpatients (17%), but only the two attachment endoleaks had to be treated byone proximal and one
distal SG extension. Overall hospital stay for the synchronous repair was12.5 ^ 6 days and thatof the simultaneous group 17.5 ^ 7 days.Thirty-
day mortality was 5% (2/42) as one patient of the simultaneous group experienced a lethal cerebral embolism during SG and one patient of the
synchronous group developed an untreatable infection. In the follow-up of 4 years, there were two vascular reinterventions but no additional
procedure-related morbidity or mortality. Conclusions: This experience shows that combined CABG and SG of thoracic or infrarenal aortic
aneurysm is a safe and less-invasive alternative to the open graft repair, especially in the older patients or patients with severe comorbidities.
q 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Arterosclerosis commonly affects different vascular areas.
Abdominal aortic aneurysms (AAA) as well as thoracic
descendingaorticaneurysms(TAA)are frequentlyassociated
with severe coronary artery disease (CAD) [1]. Patients
undergoing AAA repair are known topresent a 50% incidence
of concomitant clinically significant CAD [2]. Therapeutical
strategy and management of patients requiring operation for
CAD and aortic aneurysm (AA) repair are representing a
therapeutic challenge. The optimal timing of aneurysm repair
in patients with severe CAD is still a subject of controversial
discussions [3].
The two-stage intervention for surgical treatment of CAD
and AAA is repeatedly reported to carry enhanced risks
arising from the untreated vascular disease. The mortality
rate for patients with significant CAD undergoing conven-
tional open AAA repair is noted to be four times higher than
for patients without severe CAD [4,5]. Myocardial infarction
remains the leading cause of perioperative death following
AAA resection [6]. However, even though coronary
revascularization prior to AAA repair protects from
perioperative myocardial ischemic events, these patients
have still to be classified as high-risk cases, due to the
significantly increased tendency of aneurysm rupture [3,7,8].
Delayed repair of an AAA following coronary artery bypass
grafting (CABG) is associated with a significant increase in
mortality (33%) secondary to aneurysm rupture [7].
One-stage procedure for CABG and AAA repair is
frequently recommended to avoid severe complications in
patients requiring myocardial revascularization and aneur-
ysm repair [9,10]. Reduction in mortality and morbidity rates
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has been achieved with combined CABG/AAA procedure
besides reduced lengthofhospital stayandcosts [11,12].With
the rising interest in performing CABG on the beating heart, a
limited number of reports have recently been published
recommending the combined off-pump CABG and open
surgical AAA repair as a further optimized therapeutical
strategy [12–14].
With the introduction of commercially manufactured and
modular devices, stent-grafting (SG) has been widely
established as a therapeutical alternative for treatment of
AAs with encouraging results [15,16]. Reports on combined
procedure of CABG and SG are only sporadic so far [17,18].
According to an extensive literature review, publications
about treatment of CAD and AAA/TAA in combined
procedure with off-pump CABG and SG are completely
absent at present.
The purpose of the present study was the evaluation of
combined treatment for AAs and CAD by simultaneous and
synchronous SG and CABG in order to achieve a further
reduction of mortality and morbidity rates.
2. Patients and methods
Forty-two patients with combined CABG and SG for AA
since May 1998 have been included in a prospective non-
randomized study. Because of the experimental nature of
aortic SG and the necessity for willing long-term follow-up
controls, informed consent was obtained from all patients.
Mean age of the 38 male and four female patients was 73 ^ 14
years (range: 51–89 years). Ninety percent (38 patients) of all
patients aged over 60 years at the time of operation.
2.1. Selection of patients
All patients were suffering either from clinically signifi-
cant CAD with the presence of an associated AAA or TAA
essentially requiring treatment as well, or patients have been
referred for treatment of a symptomatic AA and presented a
concomitant severe CAD. Main study inclusion criterion was
the feasibility of aortic SG. Aortic morphological and
pathological conditions were assessed by preoperative
angiography and computerized tomography (CT) scanning
according to a previously reported method [16].
2.2. Cardiac disease
Most of the patients had typical angina symptoms (New
York Heart Association . II). According to preoperative
coronary angiography, severity of the CAD was classified in
ten patients (24%) as one-vessel disease and in nine patients
(21%) as two-vessel disease. Majority of the patients (23
patients, 55%) were suffering from a three-vessel disease.
Left ventricular ejection fraction (LVEF) was slightly
reduced in 11 out of 42 patients (26%) presenting a LVEF
between 40 and 55%. In 4 out of 42 patients (10%), LVEF
was lower than 30%. Concomitant cardiac diseases have
been valvular heart disease (4/42 patients, 10%) and cardiac
arrhythmias (5/42 patients, 12%). Thirteen out of 42 patients
(30%) had a history of prior myocardial infarction.
2.3. Aortic disease
Aortic disease (AAA in 17 and TAA in three patients) was
the primary indication for operation in 48% of patients (20/42
patients). In this group of patients, aneurysm diameter was
within 4.5–6.0 cm in 11 patients and over 6.0 cm in nine
patients. Asymptomatic AA was diagnosed for the remaining
22 patients (AAA in 19 and TAA in three) primarily referred
for CAD. Distribution of aneurysm diameter in that group was
up to 6.0 cm in 19 patients and wider than 6 cm in three
patients. The pathology of thoracic aortic disease was
atherosclerotic in four and chronic aortic type B dissection
in two patients.
2.4. Concomitant non-cardiac diseases
Concomitant non-cardiac diseases with clinical signifi-
cance have been systemic arterial hypertension (28 patients),
diabetes mellitus (five patients), chronic obstructive pulmon-
ary disease (11 patients), chronic renal failure (13 patients),
history of cerebrovascular ischemic event (four patients),
history of pulmonary embolism (two patients), obesity (13
patients) and cancer in three cases (adrenal cancer, carcinoma
of the prostata and carcinoma of the tongue root).
2.5. Timing and management of surgical interventions
Myocardial revascularization and combined aortic SG
have been performed in all the 42 patients during the same
hospitalization. Simultaneous treatment of both pathologies
was performed within a mean interval of 9 ^ 3 days in 29 out
of 42 patients (mean age 71 years; range: 51–89 years).
Preoperative mean Euroscore for this group was 8.79 ^ 3.13
and the mean aneurysm diameter was 5.9 ^ 1.2 cm (range:
4.1–10). Synchronous procedure, defined as treatment of two
different diseases within one anesthesia, was performed in 13
out of 42 patients (mean age 73 years; range: 54–89 years).
The mean Euroscore for the synchronous group was
7.0 ^ 3.16 and the mean aneurysm diameter in this group of
patients was 5.92 ^ 1.20 cm (range: 4.5–8.5). Myocardial
revascularization was performed under cardiopulmonary
bypass, cardioplegic arrest or off-pump technique, respect-
ively, according to general accepted indications. All patients
unsuitable for off-pump CABG and with any degree of renal
failure had to be treated in a simultaneous strategy to avoid the
addition of nephrotoxic effects caused by cardiopulmonary
bypass circulation during CABG and application of contrast
agent during SG.
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2.6. Coronary surgery
Coronary surgery was performed in the simultaneous
group under cardiopulmonary support in all of the 29
patients, but cardioplegic arrest was used in only 19
patients. In ten patients, satisfactory and uncomplicated
revascularization could be achieved on the unloaded beating
heart. In two patients, CABG had to be performed urgently
because of unstable lesions. Out of the synchronous group,
84.6% of patients (11/13) underwent coronary surgery in
off-pump techniques. No case of conversion to circulatory
support has become necessary. For the remaining two
patients, CABG procedure has been performed with on-
pump technique, but cardioplegic arrest was performed only
in one patient. The average number of grafts was 3.5 ^ 1.5
grafts per patient in the simultaneous group and 2.1 ^ 1.6
grafts per patient in the synchronous group.
2.7. Stent-grafting
Feasibility of SG was assessed by preoperative angio-
graphy and CT scanning. SG for TAA (six patients) and
AAA (36 patients) was performed according to the
previously reported technique [16]. All aneurysms were
treated by implantation of commercially available self-
expanding grafts. The six TAA were stented with tubular
endografts: Talent (Medtronic) n ¼ 1/Excluder (Gore and
Associates) n ¼ 5. Modular type endografts, designed as
trunk-ipsilateral components with an attachment site for the
contralateral component, were used for treatment of AAA:
Talent (Medtronic) n ¼ 3, Excluder (Gore and Associates)
n ¼ 22, Vanguard (Boston scientific) n ¼ 10, Zenith (Cook)
n ¼ 1. Local anesthesia combined with intravenous analgo-
sedation was chosen as an anesthesiologic management for
SG procedure in 24 out of 29 patients (89%) of the
simultaneous group [16,19]. In five patients, general
anesthesia was required to achieve transilliac access.
2.8. Postoperative management
All patients have been transferred to the intensive care unit
(ICU) for postoperative recovery after CAD. In the simul-
taneous group, all of the patients went directly to the normal
ward after SG. Control CT scans were performed early
postoperatively for assessment of correct SG positioning,
aneurysm sealing andexclusion of retroperitoneal hematoma.
Follow-up of all patients including CT scans was continued at
6 weeks, 6 months and yearly postoperatively according to
well-accepted criteria.
3. Results
One patient of the simultaneous group developed post-
operatively, following AAA SG, a severe hypoperfusion
syndrome of the left internal mammary artery–left anterior
descending coronary artery (LIMA–LAD) graft that required
an additional distal saphenous vein bypass grafting to the
distalLAD.Thisprocedurecouldagainbepreformedwithoff-
pump techniques. Supplementary to inotropic medication, an
intraaortic ballonpump (IABP) was inserted intraoperatively.
The balloon catheter was introduced into the femoral artery
and carefully maneuvered through the SG to its position into
the thoracic descending aorta. Throughout the following two
postoperative days, the patient’s condition required inotropic
support and intraaortic balloon counterpulsation. The IABP
could be removed at postoperative day (POD) 2. Both the
patients were operated at an emergency because unstable
coronary lesions have shown an uneventful intra- and
postoperative course after synchronous intervention for
CAD and AAA. Minor cardiac events have been the
postoperative occurrence of atrial fibrillation (seven patients,
17%) and the appearance of premature ventricular contrac-
tions in four patients (10%). Reoperations due to mediastinal
bleeding have been performed in one patient of the
synchronous group and in two patients of the simultaneous
group.
Aortic SG showed an immediate success rate of SG with
complete sealing of the aneurysm in 83% (35/42 patients),
confirmed in postoperative CT scans. In two patients (2/42,
5%), one proximal as well as one distal type-I endoleak have
been detected and immediately successfully corrected by
SG extension. Reperfusion of the excluded aneurysm
originating from the lumbar or mesenteric circulation was
treated conservatively in five patients (5/42, 12%).
Two patients needed reintubation and prolonged venti-
lation due to respiratory failure. In four patients, temporary
progression of chronic renal failure occurred (9.5%), how-
ever, without progression to terminal renal failure. Further,
chest wound infections and groin wound infections occurred
in five patients each. All wound infections have been minor-
degree infections with unproblematic healing and without a
need for surgical intervention or prolonged hospital stay.
Total duration of stay at the ICU was a mean of 3.3 ^ 3.9
days for the patients of the synchronous group. These patients
have been discharged from hospital after 12.5 ^ 6.2 days
mean. All patients after simultaneous procedure have been
transferred to the ICU for postoperative recovery after CABG
and after SG. Total length of stay at the ICU was 2.9 ^ 4.7
days (1.8 ^ 1.7 days after CABG and 1.01 ^ 3.9 days after
SG).Meandurationofhospital staywas17.5 ^ 7.3days in the
simultaneous group.
Early procedure-related mortality (30-day mortality) was
2.2% as one patient of the simultaneous group died at POD 3
due to a cerebral embolism following SG procedure. Another
patient of the synchronous group developed an untreatable
multiple organ failure and died at POD 2 after SG. Therefore,
the overall early mortality of the combined procedure was
4.8% (2/42 patients) with a strictly SG-related mortality of
2.4% (1/42 patients).
During the follow-up of 4 years, no additional procedure-
related morbidity or mortality occurred. Due to the death of
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three patients out of the simultaneous group by non-
procedure associated diseases (two cases of exacerbation of
carcinoma with lethal outcome and one lethal stroke) the
overall mortality raised to 10.9% (five patients). However,
the procedure-related mortality after completion of 4 years
of follow-up remains still at 4.3% (two patients).
4. Discussion
The coexistence of severe CAD and AA is a common
phenomenon, especially in the elderly population [1,7]. The
incidence of coronary arterosclerosis in patients presenting
with an AA can be as high as 80% [2,20]. On the other hand,
CAD patients show a high rate of coexistence of major
vascular diseases such as AAA or TAA. This frequent
coincidence of major vascular and cardiac diseases empha-
sized the importance of a precise preoperative evaluation of
the patient’s history to avoid catastrophic events arising from
unknown or suspected concomitant disease. In general,
patients referred to our institution for cardiac or major
vascular procedures undergo, in the presence of symptoms or
risk factors for concomitant vascular or cardiac diseases,
complete cardiovascular investigations preoperatively. This
includes appropriate coronary, aortic and/or peripheral
angiography as well as thoracic and/or abdominal CT/
magneticresonance tomographyscanning toachieveaccurate
diagnostic information in order to decide on the therapeutic
strategy. Abdominal ultrasonography and/or duplexsonogra-
phy prior to cardiac surgery has a leading position as a
diagnostic tool for exclusion of major abdominal aortic
diseases.
Two different surgical options are used in patients
requiring treatment of both diseases. A one-stage interven-
tion, where both diseases are corrected synchronously during
a single anesthesia, and the two-step staged procedures. Latter
strategy, especially when there is a long delay between both
procedures, carries an enhanced risk arising from the
untreated vascular disease. The increased risk of aneurysm
rupture following CABG procedure has been well documen-
ted [3,7,8] and can be as high as 30%. The leading cause of
aneurysm rupture is probably the inflammatory response,
induced by the usage of the cardiopulmonary bypass. The
inflammatory reaction triggers the activation of matrix
metalloproteinases, increased collagenase and elastase
activity [22]. This leads to the destruction of collagen and
elastin structures of the aneurysm wall. These changes in
structure and composition of the aortic wall lead to aneurysm
wall weakening, reduced tensile strength and progression
toward aneurysmal rupture [21,22]. On the other hand,
myocardial infarction remains the leading cause of perio-
perative death following AAA resection [6]. The mortality
rate for patients with significant CAD undergoing conven-
tional open AAA repair, without prior correction of the CAD,
is observed to be four times higher than for patients without
severe CAD [4,5].
One-stage procedure for CABG and AAA repair is
frequently recommended to avoid such complications [9,
10]. Reduction in mortality and morbidity rates has been
achieved with combined one-stage conventional open
procedure besides reduced length of hospital stay and
costs [11,12]. However, due to rising age of concerned
population, the one-stage repair by conventional open
surgery might be associated with increased perioperative
mortality and morbidity caused by extensive operations and
prolonged durations of procedures, as well as by con-
comitant non-vascular diseases [23].
To further optimize the outcome of combined procedures
for CABG and AA repair, especially in the elderly patients
with multifocal atherosclerosis and/or reduced organ func-
tion, less-invasive techniques are required. For the treatment
of CAD, revascularization on the beating heart or with off-
pump techniques should be encouraged. Systemic inflamma-
tory response to thecardiopulmonarybypass andcardioplegic
arrest can totally be avoided under off-pump technique, which
correlates with lower morbidity and mortality rates [24,25].
However,notall patients will be suitable foroff-pump CABG.
Iffeasible, myocardial revascularization in these cases should
beperformed onthebeatingheartwithcirculatorysupportand
ventricular unloading by on-pump technique. Avoiding
cardioplegic arrest was shown to reduce myocardial damage
and to improve postoperative outcome [25].
Abdominal or thoracic aortic SG of isolated aortic
pathologies has been proved as safe intervention and less-
invasive alternative to conventional open aneurysm repair
[15,16]. Aortic SG is performed without laparotomy or
thoracotomy, periaortic dissection, aortic cross-clamping and
their systemic and/or metabolic complications. If a simul-
taneous procedure is intended, the choice of anesthetic
management opens a further option for modulation of disease
management. As previously reported, aortic SG under local
anesthesia is a feasible and attractive alternative to avoid
disadvantages and risks of repeated general anesthesia [16,
19]. Our series shows that SG applied in the combined
treatment of CAD and aneurysm repair has a low procedural
complication rate and well acceptable mid-term results in the
follow-up. Moreover, recovery period and duration of
hospital stay are reduced. However, in contrast to these
benefits, key questions on the long-term results of this
technique are still unanswered and the evaluation of costs
for treatment involving SG is still controversially discussed.
Reasons for the reported higher hospital costs following
endovascular treatment might be an incomplete learning
curve in this rapidly evolving field as well as the markedly
higher expense for one endograft compared with a regular
vascular graft.
The performance of off-pump CABG and SG in
synchronous procedure has proved to us as an optimal
novel combination of efficient and less-invasive techniques.
However, only a limited number of patients are suitable for
this therapeutic strategy. Renal failure must be considered
as main contraindication for one-stage treatment in
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synchronous strategy when CABG cannot be achieved in
off-pump technique. Potential addition of nephrotoxic
effects caused by cardiopulmonary bypass circulation
during CABG and application of contrast agent during SG
is likely to deteriorate even a merely slightly reduced renal
function. Higher degree of left ventricular failure might
require simultaneous treatment of CAD and AA. The risk–
benefit assessment between advantages of one-stage repair
and prolonged duration of synchronous procedure must be
considered carefully from case to case.
In conclusion, aortic SG combined with CABG is a safe
and less-invasive approach to concomitant coronary artery
and aortic disease. Further improvement can be achieved by
coronary artery revascularization performed on the beating
heart or with off-pump techniques, as well as the use of local
anesthesia for simultaneous SG procedures. Nevertheless,
synchronous procedure should be performed only when
coronary morphology and ventricular function surely enable
to achieve CABG in off-pump technique or when any
restriction of renal function definitely has been excluded.
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Appendix A. Conference discussion
Dr F. Maisano (Milan, Italy): I see that in your experience all of the
OPCAB procedures were simultaneously done with the stent-grafting. Is
there any reason for that?
Dr Lachat: Generally we do perform the one-step synchronous
procedure only when the coronary revascularisation could be achieved
off-pump. We try to avoid a cumulative impairment of the renal function
due to the use of the cardiopulmonary bypass and contrast medium,
necessary for stent-grafting. So if we have to operate on cardiopulmonary
bypass, we will delay the aneurysm repair for a week. Overall, we have had
in both groups two patients showing a perioperative decrease of their renal
function, but all of the four patients went home with a normalized renal
function.
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